MDMAPharmala Biotech HoldingsMDMA info
$0.06info0.00%24h
Global rank34389
Market cap$5.28M
Change 7d-5.56%
YTD Performance-41.38%
SP500 benchmarkUnderperform
P/E-6.24
P/S13.51
Revenue$390.76K
Earnings-$572.78K
Dividend yield-
Main Sector
Healthcare

Pharmala Biotech Holdings (MDMA) Total Liabilities

MDMA Total Liabilities in 2022: $755.83K

According to Pharmala Biotech Holdings latest financial reports the total liabilities of MDMA is $755.83K, an increase of 142.82% to 2022. At the end of 2022 company had $311.27K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Pharmala Biotech Holdings is responsible for during its operational activities.

Pharmala Biotech Holdings (MDMA) Total Liabilities History from 2023 to 2022

-
Value:-

MDMA Total Liabilities by year

YearTotal liabilitiesChange
2023$755.83K142.82%
2022$311.27K206.03%
2021$101.71K-

View the Top Total Liabilies Stocks

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org